133 related articles for article (PubMed ID: 31397185)
1. The potential value of lncRNA-BC050642 in osteosarcoma origination and outcomes.
Yang Y; Fei M; Zhou X; Li Y; Jin D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1859-1866. PubMed ID: 31397185
[No Abstract] [Full Text] [Related]
2. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of long non-coding RNA HOST2 expression and its tumor-promotive function in human osteosarcoma.
Qi XD; Xu SY; Song Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):921-927. PubMed ID: 29509239
[TBL] [Abstract][Full Text] [Related]
6. Effect of lncRNA LET on proliferation and invasion of osteosarcoma cells.
Kong G; Qi XJ; Wang JF
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1609-1614. PubMed ID: 29630103
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
8. Antidifferentiation Noncoding RNA Regulates the Proliferation of Osteosarcoma Cells.
Min L; Hong S; Duan H; Zhou Y; Zhang W; Luo Y; Shi R; Tu C
Cancer Biother Radiopharm; 2016 Mar; 31(2):52-7. PubMed ID: 26986815
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
Zhao D; Wang S; Chu X; Han D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
[TBL] [Abstract][Full Text] [Related]
11. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
Deng R; Zhang J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
[TBL] [Abstract][Full Text] [Related]
12. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Zhang SZ; Cai L; Li B
Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
[TBL] [Abstract][Full Text] [Related]
13. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
Dong Z; Wang Y
Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
18. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
[TBL] [Abstract][Full Text] [Related]
19. [Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS].
Xie XK; Yang DS; Ye ZM; Tao HM
Ai Zheng; 2005 Mar; 24(3):292-7. PubMed ID: 15757529
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
Zhang JJ; Yang P; Shang XQ
Zhongguo Gu Shang; 2023 Jun; 36(6):559-64. PubMed ID: 37366099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
